Fact CheckerSign in

NCT04702932Not yet recruiting

Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies

Source: ClinicalTrials.gov · Last updated 11 Jan 2021 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Patients with monoclonal gammopathies either benign or malignant may develop inflammatory symptoms such as Schnitzler syndrome. We proposed to name those cases as monoclonal gammopathy of inflammatory significance, or MGIS. The aim of the study is to search for inflammatory pathway that may be activated in case MGIS and to search if the genetic of tumoral cell could explain those activations.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
30 (estimated)
First submitted
19 Nov 2020
Start date
1 Sept 2021
Primary completion date
1 Sept 2026
Lead sponsor
Assistance Publique - Hôpitaux de Paris
NCT number
NCT04702932

What you commit to

  • Study type: Observational
  • Planned participants: 30
  • From 1 Sept 2021 to the primary completion date, 1 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patient incapable of giving express free and informed consent.
  • Subject under guardianship, curatorship or safeguarding of justice.
  • Subject does not speak French.
  • Subject incapable of answering questions or expressing himself/herself.
  • Presence of a differential diagnosis that may explain the patient's symptoms.

Who the study is looking for

  • Patient over 18 years of age with the capacity to give express free and informed consent.
  • Patient followed in one of the services participating in the study and meeting the 2 following conditions
    • have myelodysplastic syndrome, or multiple myeloma, or monoclonal gammopathy of undetermined significance, or Schnitzler's syndrome.
    • have a fever of undetermined etiology associated with one of the following symptoms: rash, arthralgia or arthritis, serositis, abdominal pain.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Service de Médecine Interne
Coordinator of this site? Confirm its status
ParisFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.